Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies. J of Skin. 2018;2(S1):S4. doi:10.25251/skin.2.supp.4